ChemicalBook > CAS DataBase List > PD 123319 ditrifluoroacetate

PD 123319 ditrifluoroacetate

Product Name
PD 123319 ditrifluoroacetate
CAS No.
130663-39-7
Chemical Name
PD 123319 ditrifluoroacetate
Synonyms
CS-953;PD 123,319;PD123319 TFA;PD123319, >=98%;(S)-(+)-PD 123319;ditrifluoroacetate;PD-123319 TFA salt;PD-123319 free base;PD 123319 ditrifluor;PD 123,319 DITRIFLUOROACETATE
CBNumber
CB3669147
Molecular Formula
C31H32N4O3
Formula Weight
508.61
MOL File
130663-39-7.mol
More
Less

PD 123319 ditrifluoroacetate Property

Boiling point:
775.8±60.0 °C(Predicted)
Density 
1.22±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
H2O: 12 mg/mL
form 
powder
pka
2.80±0.20(Predicted)
Water Solubility 
Soluble to 100 mM in water
More
Less

Safety

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26
WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Tocris
Product number
1361
Product name
PD123319ditrifluoroacetate
Purity
≥99%(HPLC)
Packaging
10
Price
$231
Updated
2021/12/16
Tocris
Product number
1361
Product name
PD123319ditrifluoroacetate
Purity
≥99%(HPLC)
Packaging
50
Price
$903
Updated
2021/12/16
Usbiological
Product number
462090
Product name
PD 123319
Packaging
10mg
Price
$439
Updated
2021/12/16
Usbiological
Product number
256179
Product name
PD 123319 ditrifluoroacetate
Packaging
10mg
Price
$480
Updated
2021/12/16
TRC
Product number
P217705
Product name
PD123319
Packaging
10mg
Price
$140
Updated
2021/12/16
More
Less

PD 123319 ditrifluoroacetate Chemical Properties,Usage,Production

Uses

PD 123319 is a selective non-peptide angiotensin AT2 receptor antagonist.

Definition

ChEBI: An imidazopyridine consisting of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine having 4-(dimethylamino)-3-methylbenzyl, diphenylacetyl and carboxy and groups at positions 1, 5 and 6 respectively

Biological Activity

Potent, selective, non-peptide angiotensin AT 2 receptor antagonist. IC 50 values are 34 and 210 nM in rat adrenal tissue and brain respectively.

References

[1] blankley c j, hodges j c, klutchko s r, et al. synthesis and structure-activity relationships of a novel series of non-peptide angiotensin ii receptor binding inhibitors specific for the at2 subtype. journal of medicinal chemistry, 1991, 34(11): 3248-3260.
[2] boulay g, servant g, luong t t, et al. modulation of angiotensin ii binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the dup-753-sensitive angiotensin ii receptor of bovine adrenal glomerulosa. molecular pharmacology, 1992, 41(4): 809-815.
[3] siragy h. angiotensin ii receptor blockers: review of the binding characteristics. the american journal of cardiology, 1999, 84(10): 3-8.

PD 123319 ditrifluoroacetate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

PD 123319 ditrifluoroacetate Suppliers

China 82 Europe 1 Germany 3 Switzerland 2 The Netherlands 1 United Kingdom 3 United States 15 Global 107
More
Less

View Lastest Price from PD 123319 ditrifluoroacetate manufacturers

Career Henan Chemical Co
Product
PD 123,319 DITRIFLUOROACETATE 130663-39-7
Price
US $2.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
100kg
Release date
2018-12-23

130663-39-7, PD 123319 ditrifluoroacetateRelated Search:

PD 173074 PD 166285 PD 166866 PD 0325901 xav-939 Cabozantinib 2-METHOXYESTRADIOL Vismodegib (GDC-0449) S3I-201 Rapamycin L-4,5,6,7-TETRAHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE-6-CARBOXYLIC ACID 4,5,6,7-TETRAHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE-6-CARBOXYLIC ACID PD 123319 ditrifluoroacetate

  • 1-[[4-(DIMETHYLAMINO)-3-METHYLPHENYL]METHYL]-5-(DIPHENYLACETYL)-4,5,6,7-TETRAHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE-6-CARBOXYLIC ACID DITRIFLUOROACETATE
  • (3S)-9-[(4-DIMETHYLAMINO-3-METHYL-PHENYL)METHYL]-4-(2,2-DIPHENYLACETYL)-4,7,9-TRIAZABICYCLO[4.3.0]NONA-7,10-DIENE-3-CARBOXYLIC ACID
  • PD 123,319
  • PD 123,319 DITRIFLUOROACETATE
  • S(+)-1-[[4-(DIMETHYLAMINO)-3-METHYLPHENYL]METHYL]-5-(DIPHENYLACETYL)-4,5,6,7-TETRAHYDRO-1H-IMIDAZOL[4,5-C]PYRIDINE-6-CARBOXYLIC ACID DITRIFLUOROACETATE
  • PD 123,319 DITRIFLUOROACETATE POTENT AND SELECTIVE
  • 1-((4-(Dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4.5-c]pyridine-6-carboxyli
  • CS-953
  • pd 123,319 di(trifluoroacetate) salt
  • s-(+)-1-[(4-(dimethylamino)-3-methylphenyl)methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine-6-carboxylic acid ditrifluoroacetate
  • (6S)-1-[[4-(Dimethylamino)-3-methylphenyl]methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6α-carboxylic acid
  • (6S)-1-[4-(Dimethylamino)-3-methylbenzyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid
  • (6S)-1-[4-Dimethylamino-3-methylbenzyl]-5-diphenylacetyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6α-carboxylic acid
  • 1H-Imidazo(4,5-C)pyridine-6-carboxylic acid, 1-((4-(dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-, (S)-
  • 1H-IMidazo[4,5-c]pyridine-6-carboxylic acid, 1-[[4-(diMethylaMino)-3-Methylphenyl]Methyl]-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-, (6S)-
  • ditrifluoroacetate
  • (S)-(+)-PD 123319
  • (6S)-1-[[4-(Dimethylamino)-3-methylphenyl]methyl]-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid
  • PD123319 TFA
  • 1-[[4-(dimethylamino)-3-methylphenyl]methyl]-5-(2,2-diphenylacetyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridine-6-carboxylic acid
  • PD123319, >=98%
  • PD-123319 TFA salt
  • PD 123319 ditrifluoroacetate USP/EP/BP
  • PD 123319 ditrifluor
  • PD-123319 free base
  • 130663-39-7
  • C31H32N4O32CF3CO2H
  • Inhibitors
  • Angiotensin